Immuron marks surge in Travelan® sales on eve of entry into US via Walmart.com
Immuron Ltd (NASDAQ:IMRN, ASX:IMC), a biopharmaceutical company headquartered in Australia, says sales of its immune supplement Travelan® have soared.
https://www.proactiveinvestors.com.au/companies/news/1044933/immuron-marks-surge-in-travelan-sales-on-eve-of-entry-into-us-via-walmart-com-1044933.html
Filter by Year:
- Immuron files FDA application for deadly C. diff infection fight
- Immuron marks surge in Travelan® sales on eve of entry into US via Walmart.com
- Biotech Daily: Dr Boreham’s Crucible: Immuron
- The Watchlist: Immuron's Travelan sales growth, clinical pipeline achievements and upcoming milestones!
- These ASX biotechs are working with the US Department of Defense to bring new drugs to market and have a bright future ahead
- Guarding Gut Health on the Go: The Travelan® Advantage
This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.
